Skip to main content

Peer Review reports

From: Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: a single-arm, phase 2 study

Original Submission
4 Oct 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
26 Oct 2021 Reviewed Reviewer Report
12 Nov 2021 Reviewed Reviewer Report
30 Nov 2021 Author responded Author comments - Wen Zhang
Resubmission - Version 3
30 Nov 2021 Submitted Manuscript version 3
13 Dec 2021 Reviewed Reviewer Report
21 Dec 2021 Reviewed Reviewer Report
7 Jan 2022 Author responded Author comments - Wen Zhang
Resubmission - Version 4
7 Jan 2022 Submitted Manuscript version 4
18 Jan 2022 Author responded Author comments - Wen Zhang
Resubmission - Version 5
18 Jan 2022 Submitted Manuscript version 5
13 Feb 2022 Reviewed Reviewer Report
13 Feb 2022 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
23 Feb 2022 Editorially accepted
9 Mar 2022 Article published 10.1186/s12885-022-09332-7

You can find further information about peer review here.

Back to article page